These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29899783)

  • 41. Metabolism of branched-chain amino acids in maple syrup urine disease.
    Schadewaldt P; Wendel U
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S62-6. PubMed ID: 9266218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease--screened by tandem mass spectrometry.
    Lin JF; Chiu PC; Hsu HY; Lin SM; Chen YY; Hsieh KS
    Acta Paediatr Taiwan; 2004; 45(5):287-9. PubMed ID: 15868812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maple Syrup Urine Disease Complicated with Kyphoscoliosis and Myelopathy.
    Hou JW
    Pediatr Neonatol; 2016 Oct; 57(5):431-435. PubMed ID: 24486081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Typical neuroradiological diagnosis of maple syrup urine disease as a precursor to clinical diagnosis. A case report.
    Srinivasan KG; Ramprabananth S; Ushanandhini KP; Srividya S
    Neuroradiol J; 2009 Dec; 22(5):564-7. PubMed ID: 24209402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation.
    Wessel AE; Mogensen KM; Rohr F; Erick M; Neilan EG; Chopra S; Levy HL; Gray KJ; Wilkins-Haug L; Berry GT
    JPEN J Parenter Enteral Nutr; 2015 Sep; 39(7):875-9. PubMed ID: 24618664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
    Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
    Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production and characterization of murine models of classic and intermediate maple syrup urine disease.
    Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS
    BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect.
    Mescka CP; Wayhs CA; Vanzin CS; Biancini GB; Guerreiro G; Manfredini V; Souza C; Wajner M; Dutra-Filho CS; Vargas CR
    Int J Dev Neurosci; 2013 Feb; 31(1):21-4. PubMed ID: 23137711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria.
    Parsons HG; Carter RJ; Unrath M; Snyder FF
    J Inherit Metab Dis; 1990; 13(2):125-36. PubMed ID: 2116544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Living related versus deceased donor liver transplantation for maple syrup urine disease.
    Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
    Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tailoring of the diet for the individual in maple syrup urine disease: long-term home dietary treatment of an adult patient with MSUD by monitoring of daily intake with a personal computer. A case report.
    Lie IE; Haugstad S; Holm H
    Hum Nutr Appl Nutr; 1985 Apr; 39(2):130-6. PubMed ID: 3839494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency during treatment of maple syrup urine disease].
    Templier I; Reymond JL; Nguyen MA; Boujet C; Lantuejoul S; Beani JC; Leccia MT
    Ann Dermatol Venereol; 2006 Apr; 133(4):375-9. PubMed ID: 16733455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Anaesthetic Management of a Patient with Maple Syrup Urine Disease.
    Karahan MA; Sert H; Havlioğlu İ; Yüce HH
    Turk J Anaesthesiol Reanim; 2014 Dec; 42(6):355-7. PubMed ID: 27366451
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease.
    Bridi R; Araldi J; Sgarbi MB; Testa CG; Durigon K; Wajner M; Dutra-Filho CS
    Int J Dev Neurosci; 2003 Oct; 21(6):327-32. PubMed ID: 12927581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphological alterations and cell death provoked by the branched-chain alpha-amino acids accumulating in maple syrup urine disease in astrocytes from rat cerebral cortex.
    Funchal C; Gottfried C; de Almeida LM; dos Santos AQ; Wajner M; Pessoa-Pureur R
    Cell Mol Neurobiol; 2005 Aug; 25(5):851-67. PubMed ID: 16133938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
    Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
    Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eleven novel mutations of the BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease in the Chinese population: Report on eight cases.
    Li X; Ding Y; Liu Y; Ma Y; Song J; Wang Q; Li M; Qin Y; Yang Y
    Eur J Med Genet; 2015 Nov; 58(11):617-23. PubMed ID: 26453840
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease.
    Barschak AG; Sitta A; Deon M; de Oliveira MH; Haeser A; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):279-86. PubMed ID: 17091400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous branched-chain amino-acid-free solution for the treatment of metabolic decompensation episodes in Spanish pediatric patients with maple syrup urine disease.
    Sánchez-Pintos P; Meavilla S; López-Ramos MG; García-Cazorla Á; Couce ML
    Front Pediatr; 2022; 10():969741. PubMed ID: 36046474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interrupting the mechanisms of brain injury in a model of maple syrup urine disease encephalopathy.
    Zinnanti WJ; Lazovic J
    J Inherit Metab Dis; 2012 Jan; 35(1):71-9. PubMed ID: 21541722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.